I've always saw revenue for clinic use as the difficult path to increase uptake but telehealth use in Europe (massive market) will be the important driver and then ED use from clinic uptake......hence massive revenue potential. But does look like someone have been scooping these sellers, hopefully the LT and Instos (who have continue to buy on the market after buying big chunk of the CR).
rap chart, page-4215
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 427 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)